Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826)

HKG:6826 Revenue

Shanghai Haohai Biological Technology had revenue of 618.54M CNY in the quarter ending March 31, 2025, a decrease of -4.25%. This brings the company's revenue in the last twelve months to 2.65B, down -0.65% year-over-year. In the year 2024, Shanghai Haohai Biological Technology had annual revenue of 2.68B with 1.70% growth.

• Revenue (ttm): 2.65B CNY
• Revenue Growth: -0.65%
• P/S Ratio: 4.47
• Revenue / Employee: 1.23M CNY
• Employees: 2,156
• Market Cap: 12.70B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.68B	44.76M	1.70%
Dec 31, 2023	2.63B	531.47M	25.27%
Dec 31, 2022	2.10B	353.32M	20.19%
Dec 31, 2021	1.75B	425.69M	32.14%
Dec 31, 2020	1.32B	-271.07M	-16.99%